Prime Medicine, Inc. Common Stock Capital Reinvestment Ratio

Latest as of December 2024: 0.11x

Prime Medicine, Inc. Common Stock capital reinvestment ratio. Prime Medicine, Inc. Common Stock (PRME) has a Capital Reinvestment Ratio of 0.11x as of December 2024, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($1.79 Million). Check PRME capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.11x

Capex / Operating Cash Flow

Operating Cash Flow

$16.25 Million

USD

Capital Expenditures

$1.79 Million

USD

Data as of

Dec 2024

Most recent filing

Prime Medicine, Inc. Common Stock Capital Reinvestment Ratio by Year (None–None)

Prime Medicine, Inc. Common Stock capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see PRME cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow